Insider · CIK 0001917765
Alan Kazden
Files at NXL (Nexalin Technology, Inc.). First filing -, latest -.
In brief
Alan Kazden files SEC Form 4 as director at NXL (Nexalin Technology, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Alan Kazden has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | NXL Nexalin Technology, Inc. | AGrant or award Stock Option (right to buy)*derivative | +100,000 | $0.00 | $0 | 362,500 | Dec 23, 2025 |
| Sep 29, 2025 | NXL Nexalin Technology, Inc. | AGrant or award Common stockindirect: Owned by Alan and Natalie Kazden Family Trust | +36,459 | $0.00 | $0 | 119,590 | Sep 30, 2025 |
Questions about Alan Kazden
Answered from the filings on this page, as of the latest one.
Is Alan Kazden buying or selling?
Alan Kazden has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Alan Kazden's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alan Kazden has 0.
Where does Alan Kazden file Form 4?
Alan Kazden has filed Form 4 at NXL (Nexalin Technology, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.